Follow
HIV Patient Monitoring
HIV patient monitoring is assessing how well an HIV patient is responding to antiretroviral therapy, also known as ART.
-
DEC 03, 2024Drug Discovery & Development
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%.Written By: Annie LennonMAY 10, 2024Health & Medicine
University of California at San Diego researchers examined data from 34 clinical studies to determine the effects of can ...Written By: Kerry CharronNOV 09, 2023Cannabis Sciences
A study published in Health Economics revealed insights into medical cannabis patients’ patterns of product choice ...Written By: Kerry CharronJUN 23, 2023Clinical & Molecular DX
There are about 15 drops in one milliliter of blood. The viral load of an infected person could be anywhere from a few c ...Written By: Carmen LeitchAPR 20, 2020Microbiology
Past pandemics have been accompanied by a rise in a variety of mental health and neurological problems.Written By: Carmen LeitchMAR 15, 2020Microbiology
New research has suggested that after long-term follow-up, HIV is no longer detectable in a patient that was previously ...Written By: Carmen LeitchFEB 12, 2020Drug Discovery & Development
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 peo ...Written By: Annie LennonDEC 05, 2019Clinical & Molecular DX
Human immunodeficiency virus (HIV)-positive individuals are treated with antiretroviral therapies to reduce the amount o ...Written By: Tara FernandesAPR 10, 2019Drug Discovery & Development
Roughly 1.1 million people in the U.S. live with HIV with 15 percent of that population unaware they are infected. Treat ...Written By: Nouran AminDEC 26, 2018Microbiology
HIV is still a global health problem, even though antiretroviral drugs have completely changed outcomes for those that a ...Written By: Carmen LeitchNOV 14, 2017Microbiology
Zika virus is a member of the Flavivirus family which also includes the dengue, yellow fever, Japanese encephalitis, and ...Written By: Sarah HertrichNOV 12, 2016Clinical & Molecular DX
Scientists at the Imperial College London and DNA Electronics have developed a portable USB device that detects the pres ...MAR 03, 2016Clinical & Molecular DX
When one of the country’s top groups representing the interests of women’s health care physicians puts out a ...Written By: Judy O'RourkeDEC 01, 2015Clinical & Molecular DX
Truvuda, also known as PrEP, is a little blue pill that is the only FDA approved drug for prophylactic prevention agains ...APR 09, 2015Genetics & Genomics
In a first study to test a new generation of HIV antibodies in humans, an experimental therapy lowered the virus amount ...Written By: Ilene SchneiderMAR 31, 2015Genetics & Genomics
Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blo ...Written By: Ilene Schneider
DEC 03, 2024
Drug Discovery & Development
A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%.
Written By:
Annie Lennon
MAY 10, 2024
Health & Medicine
University of California at San Diego researchers examined data from 34 clinical studies to determine the effects of can
...
Written By:
Kerry Charron
NOV 09, 2023
Cannabis Sciences
A study published in Health Economics revealed insights into medical cannabis patients’ patterns of product choice
...
Written By:
Kerry Charron
JUN 23, 2023
Clinical & Molecular DX
There are about 15 drops in one milliliter of blood. The viral load of an infected person could be anywhere from a few c
...
Written By:
Carmen Leitch
APR 20, 2020
Microbiology
Past pandemics have been accompanied by a rise in a variety of mental health and neurological problems.
Written By:
Carmen Leitch
MAR 15, 2020
Microbiology
New research has suggested that after long-term follow-up, HIV is no longer detectable in a patient that was previously
...
Written By:
Carmen Leitch
FEB 12, 2020
Drug Discovery & Development
Over 45,000 cases of Wuhan Coronavirus have been reported globally, alongside over 1,100 deaths. Although over 4,700 peo
...
Written By:
Annie Lennon
DEC 05, 2019
Clinical & Molecular DX
Human immunodeficiency virus (HIV)-positive individuals are treated with antiretroviral therapies to reduce the amount o
...
Written By:
Tara Fernandes
APR 10, 2019
Drug Discovery & Development
Roughly 1.1 million people in the U.S. live with HIV with 15 percent of that population unaware they are infected. Treat
...
Written By:
Nouran Amin
DEC 26, 2018
Microbiology
HIV is still a global health problem, even though antiretroviral drugs have completely changed outcomes for those that a
...
Written By:
Carmen Leitch
NOV 14, 2017
Microbiology
Zika virus is a member of the Flavivirus family which also includes the dengue, yellow fever, Japanese encephalitis, and
...
Written By:
Sarah Hertrich
NOV 12, 2016
Clinical & Molecular DX
Scientists at the Imperial College London and DNA Electronics have developed a portable USB device that detects the pres
...
MAR 03, 2016
Clinical & Molecular DX
When one of the country’s top groups representing the interests of women’s health care physicians puts out a
...
Written By:
Judy O'Rourke
DEC 01, 2015
Clinical & Molecular DX
Truvuda, also known as PrEP, is a little blue pill that is the only FDA approved drug for prophylactic prevention agains
...
APR 09, 2015
Genetics & Genomics
In a first study to test a new generation of HIV antibodies in humans, an experimental therapy lowered the virus amount
...
Written By:
Ilene Schneider
MAR 31, 2015
Genetics & Genomics
Researchers have identified blood-based biomarkers in patients with active tuberculosis (ATB) that could lead to new blo
...
Written By:
Ilene Schneider